![Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/134b9da0-44c7-443f-9ff0-0480e770a18c/emmm201809982-abs-0001-m.jpg)
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance | EMBO Molecular Medicine
![IJMS | Free Full-Text | Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects IJMS | Free Full-Text | Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects](https://www.mdpi.com/ijms/ijms-14-00640/article_deploy/html/images/ijms-14-00640f1-1024.png)
IJMS | Free Full-Text | Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
![Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers | Nature Communications Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-34523-y/MediaObjects/41467_2022_34523_Fig1_HTML.png)
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers | Nature Communications
![PDF] BRCA 1/2 Tumors and Gene Expression Therapy for Breast Cancer Development and Metastasis | Semantic Scholar PDF] BRCA 1/2 Tumors and Gene Expression Therapy for Breast Cancer Development and Metastasis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f70c880cabe44da6f72a3c6107a84a3b9137e0b8/4-Figure3-1.png)
PDF] BRCA 1/2 Tumors and Gene Expression Therapy for Breast Cancer Development and Metastasis | Semantic Scholar
![Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43018-020-00139-8/MediaObjects/43018_2020_139_Fig1_HTML.png)
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | Nature Cancer
![Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis](http://pubs.sciepub.com/jcrt/4/5/2/image/tab1.png)
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis
![BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology](https://www.liebertpub.com/cms/10.1089/dna.2020.5644/asset/images/medium/dna.2020.5644_figure1.jpg)
BRCA1 Is a Novel Prognostic Indicator and Associates with Immune Cell Infiltration in Hepatocellular Carcinoma | DNA and Cell Biology
Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients | Oncotarget
![Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer | BMC Cancer | Full Text Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6688-8/MediaObjects/12885_2020_6688_Fig4_HTML.png)
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer | BMC Cancer | Full Text
![Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ] Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7976/1/fig-1-full.png)
Long non-coding RNA, LINC01614 as a potential biomarker for prognostic prediction in breast cancer [PeerJ]
![Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3fef50f667e7a94d557b63ba6d277af23a5057dc/3-Table1-1.png)
Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar
![A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies - Shao - 2022 - Environmental and Molecular Mutagenesis - A comprehensive literature review and meta‐analysis of the prevalence of pan‐cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies - Shao - 2022 - Environmental and Molecular Mutagenesis -](https://onlinelibrary.wiley.com/cms/asset/ec3817ae-2c28-4332-805c-a4927711d33c/em22505-fig-0001-m.jpg)